Novel thiolester compounds are disclosed which are orally effective angiotensin converting enzyme inhibitors useful in the treatment of mammalian hypertension. They have the formula, R.sub.1 -A.sub.1 -S-Z, wherein Z denotes -B-A.sub.2, R.sub.1 is H or an acyl group, A.sub.1 is a carboxylic acid containing at least one amino or imino -N-, A.sub.2 is a carboxylic acid containing at least one amino or imino -N- or a lower alkyl ester or amide thereof, B is a 2-4 carbon backbone chain in mercapto linkage to S which includes a carbonyl or sulfonyl group joined in carboxamido or sulfonamido linkage, respectively, to A.sub.2. Preferably A.sub.2 includes a 4-6 membered C-N ring or a 5 membered ring of one N, one S and 3 C atoms.
披露了新型
硫醇酯化合物,它们是口服有效的
血管紧张素转化酶抑制剂,用于治疗哺乳动物的 hypertension。它们具有以下公式,R.sub.1 -A.sub.1 -S-Z,其中 Z 表示 -B-A.sub.2,R.sub.1 是 H 或一个酰基团,A.sub.1 是至少含有一个
氨基或亚
氨基 -N- 的
羧酸,A.sub.2 是至少含有一个
氨基或亚
氨基 -N- 的
羧酸或其低级烷基
酯或
酰胺,B 是一个 2-4
碳骨架链,通过巯基连接到 S,并包括一个
碳酰基或磺酰基团,分别通过羧
酰胺或磺
酰胺连接到 A.sub.2。优选的是 A.sub.2 包含一个 4-6 成员的 C-N 环或一个由一个 N、一个 S 和 3 个 C 原子组成的 5 成员环。